Product Images Rocuronium
View Photos of Packaging, Labels & Appearance
- Structural Formula - roc04 0006 01
- figure 1 - roc04 0006 02
- figure 2 - roc04 0006 03
- figure 3 - roc04 0006 04
- Fresenius Kabi Logo - roc04 0006 05
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Rocuronium 5 mL Multiple Dose Vial Label - roc04 0006 06
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Rocuronium 5 mL Multiple Dose Vial Tray Label - roc04 0006 07
- PACKAGE LABEL - PRINCIPAL DISPLAY - Sticker Label - roc04 0006 08
Product Label Images
The following 8 images provide visual information about the product associated with Rocuronium NDC 65219-065 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structural Formula - roc04 0006 01
figure 1 - roc04 0006 02
figure 2 - roc04 0006 03
figure 3 - roc04 0006 04
Fresenius Kabi Logo - roc04 0006 05
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Rocuronium 5 mL Multiple Dose Vial Label - roc04 0006 06
This is a warning label for a pharmaceutical injectable product called "2605 Sterile". The product includes Rocuronium Bromide Injection, used as a paralyzing agent. It contains warnings of possible respiratory arrest, and the need for immediate artificial respiration facilities. Dosages and storage instructions are also included, including a warning not to freeze the product, and to use it within a limited timeframe after removal from refrigeration.*
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Rocuronium 5 mL Multiple Dose Vial Tray Label - roc04 0006 07
Rocuronium is a paralyzing agent that is administered intravenously through sterilized multiple-dose vials. It can cause respiratory arrest, therefore facilities for artificial respiration must be immediately available. Each mL of the injection contains 10 mg of rocuronium bromide and 2 mg of sodium acetate. The injection should be stored at 2°C to 8°C and should not be frozen. Opened vials should be used within 30 days and unused injection, within 60 days of removal from refrigeration. The container closure does not contain any natural rubber latex. However, the rest of the text is illegible.*
PACKAGE LABEL - PRINCIPAL DISPLAY - Sticker Label - roc04 0006 08
PARALYZING AGENT Peel off & apply - Rocuronium Bromide Injection contains 10 mg per mL and is intended for intravenous use only with a prescription. It is a paralyzing agent that can be applied after peeling off.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
